家庭血透治疗失败后转回中心血透的死亡率分析
本研究基于澳大利亚和新西兰透析与移植登记系统(ANZDATA)2005-2015年启动血透且治疗超过90天的19306例患者,采用回顾性队列设计,分析家庭血透(HHD)失败后转回中心血透(ICHD)的死亡风险。结果显示,与持续HHD相比,HHD失败后0-30天、30-90天及>90天的调整死亡风险均显著增加。
要点
- HHD失败后0-30天死亡风险显著增加(HR 3.93)。
- HHD失败后30-90天死亡风险仍高(HR 3.34)。
- HHD失败后>90天死亡风险持续升高(HR 2.29)。
核心结论
- HHD治疗失败与持续HHD相比,死亡风险显著增加,且风险存在于失败后早期和晚期。
研究设计与样本
- 回顾性队列研究,纳入ANZDATA中2005-2015年启动血透并治疗>90天的19306例患者。
主要发现
- HHD失败后0-30天调整死亡风险HR 3.93(95%CI 2.09-7.40,P<0.001)。
- HHD失败后30-90天调整死亡风险HR 3.34(95%CI 1.98-5.62,P<0.001)。
- HHD失败后>90天调整死亡风险HR 2.29(95%CI 1.84-2.85,P<0.001)。
临床怎么用
- 对HHD失败转回ICHD的患者,应警惕其死亡风险升高,尤其在转回后早期。
局限性
- 协变量记录于透析起始,可能存在残余混杂,且观察性数据缺乏HHD失败原因细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Patients on home hemodialysis (HHD) may eventually return to in-center hemodialysis (ICHD) for clinical, technical, or psychosocial reasons. We studied the mortality of patients returning to ICHD after HHD, comparing it with the mortality experience among patients receiving HHD and patients receiving ICHD without prior treatment with HHD. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: All patients represented in the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) who commenced HD during 2005-2015 and were treated for >90 days. EXPOSURE: ICHD and/or HHD, and clinical characteristics at study entry. OUTCOME: Mortality and cause of death. ANALYTICAL APPROACH: A time-varying multivariate Cox proportional hazards analysis with shared frailty was implemented to explore the association between patient treatment states and mortality. Patients were censored at the time of transplantation or change in treatment modality to peritoneal dialysis. RESULTS: A total of 19,306 patients initiated HD and were treated for >90 days. The mean age of patients was 60.8 ± 15.4 (SD) years, 62% were male, and 49% had diabetes. After HHD treatment failure, adjusted mortality was increased compared with continued HHD at 0-30 days (HR, 3.93 [95% CI, 2.09-7.40]; P < 0.001), 30-90 days (HR, 3.34 [95% CI, 1.98-5.62]; P < 0.001), and >90 days (HR, 2.29 [95% CI, 1.84-2.85]; P < 0.001). LIMITATIONS: Covariates recorded at dialysis initiation, residual confounding underlying successful initiation of HHD treatment, and observational data lacking detail on cause of HHD treatment failure. CONCLUSIONS: HHD treatment failure is associated with a significant increase in mortality compared with continued HHD. This risk was present in both the early (first 30 days and 30-90 days) and late (>90 days) periods after HHD treatment failure. Further investigation into the specific causes of treatment failure and death may highlight specific high-risk patients.
引用
- Semple DJ, Sypek M, Ullah S, et al. Mortality After Home Hemodialysis Treatment Failure and Return to In-Center Hemodialysis. Am J Kidney Dis. 2021. PMID: 34274359. doi:10.1053/j.ajkd.2021.05.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。